Serum Level of Interleukin-33 and Soluble ST2 and Their Association with Disease Activity in Patients with Behcet's Disease

Dae-Jun KIM; Seung-Ye BAEK; Mi-Kyung PARK; Kyung-Su PARK; Jae-Ho LEE; Sung-Hwan PARK; Ho-Youn KIM; Seung-Ki KWOK.
Journal of Korean Medical Science ; : 1145-1153, 2013.
Artículo en Inglés | WPRIM | ID: wpr-173143

Documentos relacionados

  1. Serum level of interleukin-33 and soluble ST2 and their association with disease activity in patients with Behcet's disease.
  2. Circulating prolactin levels and Behcet's disease: A meta-analysis.
  3. The importance of serum interleukin-20 levels in patients with Behçet's disease.
  4. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
  5. The Correlation of CD206, CD209, and Disease Severity in Behçet's Disease with Arthritis.
  6. The author response.
  7. Are soluble ST2 levels in the picogram or nanogram range in serum of healthy subjects/disease patients?
  8. Serum Cytokine Levels in Behçet's Disease.
  9. IL-38 serum levels in patients with Behcet's disease and the relationship with clinical features.
  10. Immunometabolic biomarkers of inflammation in Behçet's disease: relationship with epidemiological profile, disease activity and therapeutic regimens.